Header Logo

Connection

Mohammed Tikly to Male

Back to Details
This is a "connection" page, showing publications Mohammed Tikly has written about Male.
Mohammed Tikly
Connection Strength
1,930
Male
  1. Patient journey, disease burden, and functional disability in patients with axial spondyloarthritis in South Africa: results of International Map of Axial Spondyloarthritis (IMAS). Clin Rheumatol. 2024 Nov; 43(11):3335-3343.
    View in: PubMed
    Score: 0,104
  2. Relationship of Visceral Fat and Adipokines with Cardiometabolic Diseases in Psoriasis. Acta Derm Venereol. 2019 Dec 01; 99(13):1218-1223.
    View in: PubMed
    Score: 0,074
  3. Spectrum of cutaneous lupus erythematosus in South Africans with systemic lupus erythematosus. Lupus. 2019 Jul; 28(8):1021-1026.
    View in: PubMed
    Score: 0,072
  4. Burden of comorbidities in South Africans with systemic lupus erythematosus. Clin Rheumatol. 2019 Aug; 38(8):2077-2082.
    View in: PubMed
    Score: 0,071
  5. High burden of the metabolic syndrome and its component disorders in South Africans with psoriasis. Int J Dermatol. 2019 May; 58(5):557-562.
    View in: PubMed
    Score: 0,070
  6. HLA-DRB1 Amino Acid Positions and Residues Associated with Antibody-positive Rheumatoid Arthritis in Black South Africans. J Rheumatol. 2019 02; 46(2):138-144.
    View in: PubMed
    Score: 0,069
  7. Dysregulation of the Wnt signaling pathway in South African patients with diffuse systemic sclerosis. Clin Rheumatol. 2019 Mar; 38(3):933-938.
    View in: PubMed
    Score: 0,068
  8. Diagnostic utility of, and influence of tobacco usage and genetic predisposition on, immunoglobulin A, rheumatoid factor and anti-citrullinated peptide auto-antibodies in South African rheumatoid arthritis patients. Afr Health Sci. 2018 Jun; 18(2):295-303.
    View in: PubMed
    Score: 0,067
  9. Comparison of the diagnostic potential of three anti-citrullinated protein antibodies as adjuncts to rheumatoid factor and CCP in a cohort of South African rheumatoid arthritis patients. Rheumatol Int. 2018 Jun; 38(6):993-1001.
    View in: PubMed
    Score: 0,067
  10. Tight control of rheumatoid arthritis in a resource-constrained setting: a randomized controlled study comparing the clinical disease activity index and simplified disease activity index. Rheumatology (Oxford). 2015 Jun; 54(6):1033-8.
    View in: PubMed
    Score: 0,053
  11. Immunochip identifies novel, and replicates known, genetic risk loci for rheumatoid arthritis in black South Africans. Mol Med. 2014 Aug 14; 20:341-9.
    View in: PubMed
    Score: 0,052
  12. Effect of human immunodeficiency virus infection on disease activity in rheumatoid arthritis: a retrospective study in South Africans. J Rheumatol. 2014 Aug; 41(8):1645-9.
    View in: PubMed
    Score: 0,051
  13. A prospective study of anti-tumor necrosis factor therapy in South African rheumatoid arthritis patients. Int J Rheum Dis. 2016 Jun; 19(6):594-9.
    View in: PubMed
    Score: 0,050
  14. Juvenile dermatomyositis in South African children is characterised by frequent dystropic calcification: a cross sectional study. Pediatr Rheumatol Online J. 2014 Jan 07; 12:2.
    View in: PubMed
    Score: 0,049
  15. Patterns and predictors of joint damage as assessed by the rheumatoid arthritis articular damage (RAAD) score in South Africans with established rheumatoid arthritis. Clin Rheumatol. 2013 Dec; 32(12):1711-7.
    View in: PubMed
    Score: 0,048
  16. Early diagnosis and treatment of ankylosing spondylitis in Africa and the Middle East. Clin Rheumatol. 2012 Nov; 31(11):1633-9.
    View in: PubMed
    Score: 0,045
  17. Exaggerated circulating Th-1 cytokine response in early rheumatoid arthritis patients with nodules. Cytokine. 2012 Nov; 60(2):561-4.
    View in: PubMed
    Score: 0,045
  18. Functional disability and health-related quality of life in South Africans with early rheumatoid arthritis. Scand J Rheumatol. 2012 Oct; 41(5):366-74.
    View in: PubMed
    Score: 0,045
  19. Differential gene expression of MMP-1, TIMP-1 and HGF in clinically involved and uninvolved skin in South Africans with SSc. Rheumatology (Oxford). 2012 Jun; 51(6):1049-52.
    View in: PubMed
    Score: 0,043
  20. Response to traditional disease-modifying anti-rheumatic drugs in indigent South Africans with early rheumatoid arthritis. Clin Rheumatol. 2012 Apr; 31(4):613-9.
    View in: PubMed
    Score: 0,043
  21. The scourge of HIV infection in sub-Saharan Africa -- a rheumatological perspective. J Rheumatol. 2011 Jun; 38(6):973-4.
    View in: PubMed
    Score: 0,041
  22. The diagnostic utility of the anti-CCP antibody test is no better than rheumatoid factor in South Africans with early rheumatoid arthritis. Clin Rheumatol. 2010 Jun; 29(6):615-8.
    View in: PubMed
    Score: 0,038
  23. Clinical and serological correlates of antinucleosome antibodies in South Africans with systemic lupus erythematosus. Clin Rheumatol. 2007 Dec; 26(12):2121-2125.
    View in: PubMed
    Score: 0,031
  24. Purulent pericarditis due to co-infection with Streptococcus pneumoniae and Mycobacterium tuberculosis in a patient with features of advanced HIV infection. BMC Infect Dis. 2007 Mar 08; 7:12.
    View in: PubMed
    Score: 0,031
  25. Functional disability and health-related quality of life in South Africans with rheumatoid arthritis and systemic lupus erythematosus. Clin Rheumatol. 2007 Jan; 26(1):24-9.
    View in: PubMed
    Score: 0,029
  26. Lipid peroxidation and trace elements in systemic sclerosis. Clin Rheumatol. 2006 May; 25(3):320-4.
    View in: PubMed
    Score: 0,028
  27. Oxygen free radical scavenger enzyme polymorphisms in systemic sclerosis. Free Radic Biol Med. 2004 Jun 01; 36(11):1403-7.
    View in: PubMed
    Score: 0,025
  28. A longitudinal study of rheumatoid arthritis in South Africans. MedGenMed. 2003 Feb 05; 5(1):2.
    View in: PubMed
    Score: 0,023
  29. Rheumatic diseases in Africa. Nat Rev Rheumatol. 2021 06; 17(6):363-374.
    View in: PubMed
    Score: 0,020
  30. The impact of COVID-19 on rheumatology practice across Africa. Rheumatology (Oxford). 2021 01 05; 60(1):392-398.
    View in: PubMed
    Score: 0,020
  31. Systemic sclerosis in sub-Saharan Africa: a systematic review. Pan Afr Med J. 2020; 37:176.
    View in: PubMed
    Score: 0,020
  32. Racial differences in systemic sclerosis disease presentation: a European Scleroderma Trials and Research group study. Rheumatology (Oxford). 2020 Jul 01; 59(7):1684-1694.
    View in: PubMed
    Score: 0,019
  33. Tobacco-Derived Lipopolysaccharide, Not Microbial Translocation, as a Potential Contributor to the Pathogenesis of Rheumatoid Arthritis. Mediators Inflamm. 2019; 2019:4693870.
    View in: PubMed
    Score: 0,018
  34. Clinical and laboratory manifestations of systemic sclerosis (scleroderma) in Black South Africans. Rheumatology (Oxford). 1999 May; 38(5):397-400.
    View in: PubMed
    Score: 0,018
  35. Living with systemic lupus erythematosus in South Africa: a bitter pill to swallow. Health Qual Life Outcomes. 2019 Apr 16; 17(1):65.
    View in: PubMed
    Score: 0,018
  36. Autoantibody status is not associated with early treatment response to first-line methotrexate in patients with early rheumatoid arthritis. Rheumatology (Oxford). 2019 01 01; 58(1):149-153.
    View in: PubMed
    Score: 0,017
  37. Mutations of FAM111B gene are not associated with Systemic Sclerosis. Sci Rep. 2018 10 30; 8(1):15988.
    View in: PubMed
    Score: 0,017
  38. Gender differences in early systemic sclerosis patients: a report from the EULAR scleroderma trials and research group (EUSTAR) database. Clin Exp Rheumatol. 2018 Jul-Aug; 36 Suppl 113(4):68-75.
    View in: PubMed
    Score: 0,017
  39. Differences associated with age at onset in early systemic sclerosis patients: a report from the EULAR Scleroderma Trials and Research Group (EUSTAR) database. Scand J Rheumatol. 2019 Jan; 48(1):42-51.
    View in: PubMed
    Score: 0,017
  40. Light intensity physical activity increases and sedentary behavior decreases following total knee arthroplasty in patients with osteoarthritis. Knee Surg Sports Traumatol Arthrosc. 2019 Jul; 27(7):2196-2205.
    View in: PubMed
    Score: 0,017
  41. Risk factors for gout: a hospital-based study in urban black South Africans. Rev Rhum Engl Ed. 1998 Apr; 65(4):225-31.
    View in: PubMed
    Score: 0,017
  42. Interstitial lung disease in South Africans with systemic sclerosis. Rheumatol Int. 2018 Apr; 38(4):657-662.
    View in: PubMed
    Score: 0,016
  43. Mapping and predicting mortality from systemic sclerosis. Ann Rheum Dis. 2017 11; 76(11):1897-1905.
    View in: PubMed
    Score: 0,016
  44. Clinical determinants of elevated systolic pulmonary artery pressure measured by transthoracic Doppler echocardiography in early systemic sclerosis. Clin Exp Rheumatol. 2017 Sep-Oct; 35 Suppl 106(4):114-121.
    View in: PubMed
    Score: 0,016
  45. Incidences and Risk Factors of Organ Manifestations in the Early Course of Systemic Sclerosis: A Longitudinal EUSTAR Study. PLoS One. 2016; 11(10):e0163894.
    View in: PubMed
    Score: 0,015
  46. Pitfalls in the assessment of smoking status detected in a cohort of South African RA patients. Rheumatol Int. 2016 Oct; 36(10):1365-9.
    View in: PubMed
    Score: 0,015
  47. Autoantibodies in black South Africans with systemic lupus erythematosus: spectrum and clinical associations. Clin Rheumatol. 1996 May; 15(3):261-5.
    View in: PubMed
    Score: 0,014
  48. Autoantibodies in black South Africans with systemic lupus erythematosus: spectrum and clinical associations. Clin Rheumatol. 1996 Mar; 15(2):143-7.
    View in: PubMed
    Score: 0,014
  49. Incidence and predictors of cutaneous manifestations during the early course of systemic sclerosis: a 10-year longitudinal study from the EUSTAR database. Ann Rheum Dis. 2016 07; 75(7):1285-92.
    View in: PubMed
    Score: 0,014
  50. Circulating anti-citrullinated peptide antibodies, cytokines and genotype as biomarkers of response to disease-modifying antirheumatic drug therapy in early rheumatoid arthritis. BMC Musculoskelet Disord. 2015 May 29; 16:130.
    View in: PubMed
    Score: 0,014
  51. A three month controlled intervention of intermittent whole body vibration designed to improve functional ability and attenuate bone loss in patients with rheumatoid arthritis. BMC Musculoskelet Disord. 2014 Nov 29; 15:403.
    View in: PubMed
    Score: 0,013
  52. Genetic diversity in black South Africans from Soweto. BMC Genomics. 2013 Sep 23; 14:644.
    View in: PubMed
    Score: 0,012
  53. HLA-DRB1 shared epitope genotyping using the revised classification and its association with circulating autoantibodies, acute phase reactants, cytokines and clinical indices of disease activity in a cohort of South African rheumatoid arthritis patients. Arthritis Res Ther. 2011; 13(5):R160.
    View in: PubMed
    Score: 0,011
  54. Characteristics of joint involvement and relationships with systemic inflammation in systemic sclerosis: results from the EULAR Scleroderma Trial and Research Group (EUSTAR) database. J Rheumatol. 2010 Jul; 37(7):1488-501.
    View in: PubMed
    Score: 0,010
  55. Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database. Ann Rheum Dis. 2010 Oct; 69(10):1809-15.
    View in: PubMed
    Score: 0,010
  56. Interleukin-1 receptor antagonist gene polymorphisms are associated with disease severity in Black South Africans with rheumatoid arthritis. Joint Bone Spine. 2008 Jul; 75(4):422-5.
    View in: PubMed
    Score: 0,008
  57. Computed tomographic findings in amebic brain abscess. S Afr Med J. 1988 Feb 20; 73(4):258-9.
    View in: PubMed
    Score: 0,008
  58. Causes and predictors of death in South Africans with systemic lupus erythematosus. Rheumatology (Oxford). 2007 Sep; 46(9):1487-91.
    View in: PubMed
    Score: 0,008
  59. Normal haematological reference values in the adult black population of the Witwatersrand. S Afr Med J. 1987 Jul 18; 72(2):135-6.
    View in: PubMed
    Score: 0,008
  60. Ehlers-Danlos syndrome type IV in a young man. J Rheumatol. 2006 Oct; 33(10):2091-6.
    View in: PubMed
    Score: 0,007
  61. Osteoarthritis: clinical guideline 2003. S Afr Med J. 2003 Dec; 93(12 Pt 2):972-90.
    View in: PubMed
    Score: 0,006
  62. Rheumatoid arthritis susceptibility and interleukin 10: a study of two ethnically diverse populations. Rheumatology (Oxford). 2003 Jan; 42(1):149-53.
    View in: PubMed
    Score: 0,006
  63. Slowing of disease progression in rheumatoid arthritis patients during long-term treatment with leflunomide or sulfasalazine. Scand J Rheumatol. 2001; 30(3):135-42.
    View in: PubMed
    Score: 0,005
  64. A comparison of the efficacy and safety of leflunomide and methotrexate for the treatment of rheumatoid arthritis. Rheumatology (Oxford). 2000 Jun; 39(6):655-65.
    View in: PubMed
    Score: 0,005
  65. Chorea in the antiphospholipid syndrome. Clinical, radiologic, and immunologic characteristics of 50 patients from our clinics and the recent literature. Medicine (Baltimore). 1997 May; 76(3):203-12.
    View in: PubMed
    Score: 0,004
  66. HLA class II antigens associated with systemic lupus erythematosus in black South Africans. Ann Rheum Dis. 1995 Aug; 54(8):678-80.
    View in: PubMed
    Score: 0,003
  67. Interleukin 1 beta, hand and foot bone mineral content and the development of joint erosions in rheumatoid arthritis. Ann Rheum Dis. 1994 Aug; 53(8):543-6.
    View in: PubMed
    Score: 0,003
  68. HLA-DR antigens and rheumatoid arthritis in black South Africans: a study of ethnic groups. Tissue Antigens. 1992 Mar; 39(3):138-40.
    View in: PubMed
    Score: 0,003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.